United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$380Mraised across 2 rounds since 2026, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
General Catalyst
RA Capital Management
ARCH Venture Partners
Janus Henderson Investors
Catalio Capital ManagementSource recorded
General CatalystRA Capital ManagementARCH Venture Partners
Cormorant Asset ManagementCatalio Capital ManagementSource recorded
From Parabilis Medicines's own website: 3 on the team.
AdvisersEdward Fitzgerald
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
This firm lists Parabilis Medicines as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Parabilis Medicines's investors include General Catalyst, RA Capital Management, ARCH Venture Partners, Catalio Capital Management and Janus Henderson Investors, and 1 more on record.
Parabilis Medicines has raised $380M across 2 rounds since 2026.
Parabilis Medicines's most recent round was an Undisclosed round of $75M in Jun 2026.
Parabilis Medicines's largest round on record is $305M (Series F), in Jan 2026.
Parabilis Medicines's first round on record, in Jan 2026, was backed by General Catalyst, RA Capital Management and ARCH Venture Partners and 2 others.
Parabilis Medicines's latest named round is an Undisclosed round, in Jun 2026.
Parabilis Medicines is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
